VintaProcess
VintaProcess

Our advanced Intensified Adherent Technology
simplifies production into a single stream, enabling us to
lower costs, enhance quality, and accelerate timelines.

VintaProcess

VintaProcess generates high-yield, high-purity viral vectors
for clinical and commercial cell and gene therapies.
This scalable, small footprint platform was designed to
exceed the production of a 200L bioreactor with fewer
impurities while achieving 95% full capsids.

5x

increase in high-purity
vector production

3x

less impurities
 

30%

less materials used
 

95%

full capsids
 

Platform Overview

VintaProcess uses small footprint bioreactors that
require less batches than commonly used stirred tank
bioreactors. The result is fewer production runs, less
consumables, less unit operations and reduced time
needed for operator intervention.

  • VintaCell

    Ready-to-use, high-producing
    cGMP cell line.

  • VintaSeed

    Reduced cell culture leveraging
    innovation in surface area
    amplification technology.

  • VintaFect

    Proprietary transfection reagent
    with efficiency at all scales.

  • VintaSep

    Reduced and universal
    high-yield purification.

  • VintaDP

    Proprietary final formulations specific
    to virus and serotype stability.

Speed from Vial Thaw to Final Fill

VintaBio 50% Faster
VintaBio 50% Faster
Intensified Adherent
Intensified Adherent

Why Intensified Adherent over Suspension?

Forcing cells into suspension disrupts their native
adherent state leading to decreased production efficiency.
Our intensified adherent technology keeps cells in their
natural state to boost per cell output with enhanced
transfection efficiency, streamlined harvest, and simplified
downstream processing.

Comparison

VintaProcess

Natural state of HEK293 cell growth

Improved transfection efficiency

Next-generation small footprint bioreactor

Cleaner harvest material with less DSP

Speed to clinic

Suspension

Adaptation required for HEK293 cell growth

Extensive and costly development for high transfection efficiency

Large Stirred Tank Reactors (STRs) optimized for Mabs

Dirtier harvest material with extensive DSP

Slower advancement to clinics